Latest News for: biased agonist

Edit

Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress

Hastings Tribune 26 Mar 2025
MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is being studied in multiple Phase 2b clinical trials with read-outs beginning mid-2025 ... .
  • 1
×